American Society of Health-System Pharmacists (ASHP). 2009a. ASHP guidelines: Minimum standard for pharmacies in hospitals. In Best Practices for Hospital and Health-System Pharmacy. Bethesda, MD: American Society of Health-System Pharmacists, p. 379.
American Society of Health-System Pharmacists (ASHP). 2009b. ASHP statement on the pharmacy and therapeutics committee. In Best Practices for Hospital and Health-System Pharmacy. Bethesda, MD: American Society of Health-System Pharmacists, p. 126.
Barker KN, Flynn EA, Pepper AG, et al. 2002. Medication errors in 36 health care facilities. Arch Intern Med 162:1897.
Bates DW, Cullen DJ, Laird N, et al; the ADE Prevention Study Group. 1996. Incidence of adverse drug events and potential adverse drug events. JAMA 274:29.
Bates DW, Spell N, Cullen DJ, et al; the Adverse Drug Events Prevention Study Group. 1997. The costs of adverse drug events in hospitalized patients. JAMA 222:307.
Bennis W. 2003. On Becoming a Leader. Cambridge, MA: Perseus Publishing.
Bond CA, Raehl CL, Franke T. 2000. Clinical pharmacy services, pharmacy staffing, and the total cost of care in Untied States hospitals. Pharmacotherapy 20:609.
Bond CA, Raehl CL, Franke T. 2002. Clinical pharmacy services, pharmacy staffing, and medication errors in Untied States hospitals. Pharmacotherapy 22:134.
Bond CA, Raehl CL. 2006. Clinical pharmacy services, pharmacy staffing, and adverse drug reactions in Untied States hospitals. Pharmacotherapy 26:735.
Classen DC, Pestonik SL, Evans RS, et al. 1991. Computerized surveillance of adverse drug events in hospitalized patients. JAMA 266:2847.
Classen DC, Pestotnik SL, Evans RS, et al. 1997. Adverse drug events in hospitalized patients: Excess length of stay, extra costs, and attributable mortality. JAMA 277:301.
Cullen DJ, Bates DW, Small SD, et al. 1995. The incident reporting system does not detect adverse events. Jt Comm J Qual Improv 21:541.
Doloresco F, Fominaya C, Schumock GT, et al. 2011. Projecting future drug expenditures – 2011. Am J Health Syst Pharm 68:e1.
Hepler CD, Strand LM. 1990. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm 47:533.
Knapp DA. 2002. Professionally determined need for pharmacy services in 2020. Am J Pharm Educ 66:421.
Kohn LT, Corrigan JM, Donaldson MS. 1999. To Err Is Human: Building a Safer Helath System. Washington, DC: Institute of Medicine.
Leape LL. 1994. Error in medicine. JAMA 272:1851.
Leape LL. 2002. Reporting of adverse events. N Engl J Med 347:1633.
Leape LL, Brenan TA, Laird N, et al. 1991. The nature of adverse events in hospitalized patients: Results of the Harvard medial practice study II. N Engl J Med 324:377.
Leape LL, Bates DW, Cullen DJ, et al; the ADE Prevention Study Group. 1995. Systems analysis of adverse drug events. JAMA 274:35.
Pierpaoli PG. 1987. Management diplomacy: Myths and methods. Am J Hosp Pharm 44:297.
Poon EG, Cina JL, Churchill W, et al. 2006. Medication dispensing errors and potential adverse drug events before and after implementing bar code technology in the pharmacy. Ann Intern Med 145:426.
Shortell SM. 1985. High-performing health care organizations: Guidelines for the pursuit of excellence. Hosp Health Serv Adm 30:8.
Stelfox HT, Palmisani S, Scurlock C, et al. 2006. The “To Err is Human” report and the patient safety literature. Qual Saf Health Care 15:174.
Strand LM, Guerrero RM, Nickman NA, Morley PC. 1990. Integrated patient-specific model of pharmacy practice. Am J Hosp Pharm 47:550.
The Joint Commission. 2010. 2011 Comprehensive Accreditation Manual for Hospitals (CAMH): The Official Handbook. Oakbrook Terrace, IL: Joint Commission Resources.
Vermeulen LC, Rough SS, Thielhe TS, et al. 2007. Strategic approach for improving the medication-use process in health-systems: The high-performance pharmacy practice framework. Am J Health Syst Pharm 64:1699.
Zelmer WA. 1986. Perspectives on Hilton Head. Am J Hosp Pharm 43:1439.